929029-32-3Relevant articles and documents
ANDROGEN RECEPTOR PROTEIN DEGRADERS
-
Paragraph 0178; 0262, (2020/07/21)
The present disclosure provides compounds represented by Formula (I): A—L—B (I), and the salts or solvates thereof, wherein A, L, and B are as defined in the specification. Compounds having Formula (I) are androgen receptor degraders useful for the treatment of cancer.
METHODS OF TREATING ADVANCED PROSTATE CANCER
-
, (2018/11/21)
Provided herein are methods for treating metastatic prostate cancer using anti-androgen compounds and radionuclide-labeled androgens.